The health economic burden of dengue in Germany: a retrospective analysis of statutory health insurance claims data
Dengue poses a sizable health economic burden in Germany in the year following diagnosis as it increases healthcare resource utilization, sick leave days, and healthcare-related costs compared to individuals without dengue. The findings highlight the need for targeted public health interventions to mitigate the impact of dengue.
Authors
- Wolfgang Greiner (ORCID: https://orcid.org/0000-0001-9552-6969)
- T Viering
- Elizabeth Goodman (ORCID: https://orcid.org/0000-0002-9640-9884)
- S Schnaidt
- Christian Jacob (ORCID: https://orcid.org/0000-0001-6960-728X)
- L. Láng
- Kim Maren Schneider
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Bielefeld University (DE)
- Hochschule Bielefeld (DE)
- NewConceptOncology (Germany) (DE)
- MSD (Germany) (DE)
Publication Details
- Journal
- Infectious Diseases Now
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1016/j.idnow.2025.105107
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Merck
- Merck Sharp and Dohme